Safety and biodistribution of (111)In-amatuximab in patients with mesothelin expressing cancers using Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) imaging

Amatuximab is a chimeric high-affinity monoclonal IgG1/k antibody targeting mesothelin that is being developed for treatment of mesothelin-expressing cancers. Considering the ongoing clinical development of amatuximab in these cancers, our objective was to characterize the biodistribution, and dosim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindenberg, Liza, Thomas, Anish, Adler, Stephen, Mena, Esther, Kurdziel, Karen, Maltzman, Julia, Wallin, Bruce, Hoffman, Kimberly, Pastan, Ira, Paik, Chang Hum, Choyke, Peter, Hassan, Raffit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414206/
https://www.ncbi.nlm.nih.gov/pubmed/25756664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414206/
https://www.ncbi.nlm.nih.gov/pubmed/25756664

Ejemplares similares